Olanzapine is an atypical antipsychotic, approved by the FDA in 1996. Olanzapine is manufactured and marketed by the pharmaceutical company Eli Lilly and Company, whose patent for olanzapine proper ends in 2011. This compound belongs to the thienodiazepines. These are heteropolycyclic containing a thiophene ring fused to a diazepine ring.
OLANZAPINE
Structure
Product Description
Details |
|
|---|---|
Chemical Name |
OLANZAPINE |
IUPAC Name |
2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine |
CAS Number |
132539-06-1 |
Molecular Formula |
C17H20N4S |
Synonyms |
Oliza;Oltal;lanzac;Larmac;Oleanz;ZYPREXA;Integrol;LY-170053;OLANZAPINE;OLANZAPINE FORM I |
Application |
Anti-psychotic |